Calcium in PDB 2vdp: Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Protein crystallography data
The structure of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv, PDB code: 2vdp
was solved by
T.A.Springer,
J.Zhu,
T.Xiao,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
46.23 /
2.80
|
Space group
|
P 32 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
148.429,
148.429,
177.160,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
15.6 /
20.4
|
Other elements in 2vdp:
The structure of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv also contains other interesting chemical elements:
Calcium Binding Sites:
The binding sites of Calcium atom in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
(pdb code 2vdp). This binding sites where shown within
5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the
Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv, PDB code: 2vdp:
Jump to Calcium binding site number:
1;
2;
3;
4;
5;
6;
Calcium binding site 1 out
of 6 in 2vdp
Go back to
Calcium Binding Sites List in 2vdp
Calcium binding site 1 out
of 6 in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 1 of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca2004
b:62.8
occ:1.00
|
OD2
|
A:ASP245
|
2.3
|
59.9
|
1.0
|
O
|
A:THR250
|
2.4
|
50.4
|
1.0
|
O
|
A:ASP247
|
2.4
|
59.7
|
1.0
|
OE1
|
A:GLU252
|
2.4
|
51.5
|
1.0
|
OE2
|
A:GLU243
|
2.4
|
41.3
|
1.0
|
OG1
|
A:THR250
|
2.5
|
53.5
|
1.0
|
OE1
|
A:GLU243
|
2.6
|
43.6
|
1.0
|
OE2
|
A:GLU252
|
2.6
|
52.0
|
1.0
|
CD
|
A:GLU243
|
2.8
|
43.0
|
1.0
|
CD
|
A:GLU252
|
2.9
|
51.3
|
1.0
|
C
|
A:THR250
|
3.2
|
50.2
|
1.0
|
CG
|
A:ASP245
|
3.2
|
59.5
|
1.0
|
C
|
A:ASP247
|
3.5
|
60.7
|
1.0
|
OD1
|
A:ASP245
|
3.6
|
60.0
|
1.0
|
CB
|
A:THR250
|
3.6
|
54.9
|
1.0
|
CA
|
A:THR250
|
3.8
|
53.5
|
1.0
|
N
|
A:ASP247
|
4.0
|
62.1
|
1.0
|
N
|
A:THR250
|
4.0
|
56.9
|
1.0
|
CA
|
A:ASP247
|
4.1
|
62.1
|
1.0
|
N
|
A:THR251
|
4.1
|
49.7
|
1.0
|
CB
|
A:ASP247
|
4.2
|
62.2
|
1.0
|
CG
|
A:GLU243
|
4.3
|
42.0
|
1.0
|
CG
|
A:GLU252
|
4.4
|
50.2
|
1.0
|
CA
|
A:THR251
|
4.4
|
51.7
|
1.0
|
N
|
A:ASP245
|
4.5
|
55.8
|
1.0
|
N
|
A:LEU248
|
4.5
|
62.0
|
1.0
|
CB
|
A:ASP245
|
4.6
|
58.5
|
1.0
|
C
|
A:THR251
|
4.7
|
50.1
|
1.0
|
N
|
A:GLU252
|
4.7
|
48.4
|
1.0
|
N
|
A:PHE244
|
4.7
|
48.0
|
1.0
|
CA
|
A:LEU248
|
4.8
|
63.4
|
1.0
|
CG
|
A:ASP247
|
4.8
|
62.0
|
1.0
|
CA
|
A:GLU243
|
4.8
|
40.6
|
1.0
|
CA
|
A:ASP245
|
4.8
|
57.1
|
1.0
|
CG2
|
A:THR250
|
4.9
|
56.0
|
1.0
|
C
|
A:ASP245
|
4.9
|
57.2
|
1.0
|
N
|
A:GLY246
|
4.9
|
57.5
|
1.0
|
C
|
A:LEU248
|
5.0
|
62.7
|
1.0
|
CB
|
A:GLU243
|
5.0
|
40.4
|
1.0
|
|
Calcium binding site 2 out
of 6 in 2vdp
Go back to
Calcium Binding Sites List in 2vdp
Calcium binding site 2 out
of 6 in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 2 of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca2005
b:57.5
occ:1.00
|
OD1
|
A:ASN299
|
2.2
|
54.2
|
1.0
|
O
|
A:HOH4187
|
2.2
|
57.1
|
1.0
|
OD1
|
A:ASP297
|
2.3
|
53.9
|
1.0
|
O
|
A:ARG303
|
2.4
|
46.8
|
1.0
|
OD1
|
A:ASP301
|
2.5
|
42.5
|
1.0
|
OD1
|
A:ASP305
|
2.5
|
48.7
|
1.0
|
OD2
|
A:ASP305
|
2.7
|
51.3
|
1.0
|
CG
|
A:ASP305
|
2.9
|
50.8
|
1.0
|
CG
|
A:ASN299
|
3.3
|
51.8
|
1.0
|
CG
|
A:ASP297
|
3.4
|
53.1
|
1.0
|
CG
|
A:ASP301
|
3.4
|
45.0
|
1.0
|
C
|
A:ARG303
|
3.6
|
51.5
|
1.0
|
OD2
|
A:ASP301
|
3.8
|
45.9
|
1.0
|
ND2
|
A:ASN299
|
3.9
|
50.5
|
1.0
|
N
|
A:ARG303
|
4.1
|
50.0
|
1.0
|
CA
|
A:ASP297
|
4.1
|
54.6
|
1.0
|
CB
|
A:ASP297
|
4.1
|
53.8
|
1.0
|
N
|
A:ASN299
|
4.2
|
48.2
|
1.0
|
CA
|
A:ARG303
|
4.2
|
52.5
|
1.0
|
CB
|
A:ARG303
|
4.2
|
54.1
|
1.0
|
N
|
A:VAL298
|
4.3
|
54.5
|
1.0
|
OD2
|
A:ASP297
|
4.3
|
53.3
|
1.0
|
CB
|
A:ASP305
|
4.4
|
51.3
|
1.0
|
CD2
|
A:LEU332
|
4.5
|
51.9
|
1.0
|
CB
|
A:ASN299
|
4.5
|
50.4
|
1.0
|
N
|
A:ASP305
|
4.5
|
54.1
|
1.0
|
C
|
A:ASP297
|
4.6
|
55.2
|
1.0
|
C
|
A:HIS304
|
4.6
|
54.6
|
1.0
|
N
|
A:ASP301
|
4.6
|
43.9
|
1.0
|
N
|
A:HIS304
|
4.7
|
53.6
|
1.0
|
CA
|
A:ASN299
|
4.7
|
48.2
|
1.0
|
CB
|
A:ASP301
|
4.7
|
45.8
|
1.0
|
C
|
A:ASN299
|
4.9
|
45.8
|
1.0
|
N
|
A:GLN333
|
4.9
|
54.8
|
1.0
|
N
|
A:GLY300
|
4.9
|
47.5
|
1.0
|
CA
|
A:ASP305
|
4.9
|
52.5
|
1.0
|
O
|
A:GLN333
|
4.9
|
55.7
|
1.0
|
O
|
A:HIS304
|
4.9
|
52.4
|
1.0
|
CA
|
A:HIS304
|
5.0
|
54.6
|
1.0
|
|
Calcium binding site 3 out
of 6 in 2vdp
Go back to
Calcium Binding Sites List in 2vdp
Calcium binding site 3 out
of 6 in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 3 of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca2006
b:66.3
occ:1.00
|
OD1
|
A:ASP367
|
2.3
|
50.5
|
1.0
|
O
|
A:TYR371
|
2.3
|
54.1
|
1.0
|
O
|
A:HOH4200
|
2.3
|
52.4
|
1.0
|
OD2
|
A:ASP365
|
2.5
|
58.2
|
1.0
|
OD1
|
A:ASP373
|
2.6
|
68.2
|
1.0
|
OD1
|
A:ASP369
|
2.7
|
55.5
|
1.0
|
OD2
|
A:ASP373
|
2.7
|
68.2
|
1.0
|
CG
|
A:ASP373
|
3.0
|
66.2
|
1.0
|
CG
|
A:ASP367
|
3.4
|
53.7
|
1.0
|
CG
|
A:ASP369
|
3.4
|
55.1
|
1.0
|
C
|
A:TYR371
|
3.5
|
54.4
|
1.0
|
CG
|
A:ASP365
|
3.6
|
57.9
|
1.0
|
OD2
|
A:ASP369
|
3.7
|
54.9
|
1.0
|
OD2
|
A:ASP367
|
3.8
|
56.1
|
1.0
|
N
|
A:ASP367
|
4.1
|
56.8
|
1.0
|
N
|
A:LEU366
|
4.2
|
58.5
|
1.0
|
CA
|
A:ASP365
|
4.2
|
59.1
|
1.0
|
N
|
A:ASP369
|
4.2
|
55.6
|
1.0
|
N
|
A:TYR371
|
4.3
|
53.1
|
1.0
|
OD1
|
A:ASP365
|
4.3
|
56.8
|
1.0
|
CA
|
A:TYR371
|
4.3
|
53.7
|
1.0
|
N
|
A:ARG368
|
4.4
|
57.5
|
1.0
|
C
|
A:ASP365
|
4.5
|
58.9
|
1.0
|
CB
|
A:TYR371
|
4.5
|
52.0
|
1.0
|
CB
|
A:ASP365
|
4.5
|
59.4
|
1.0
|
N
|
A:ASN372
|
4.5
|
54.3
|
1.0
|
CB
|
A:ASP373
|
4.5
|
61.8
|
1.0
|
C
|
A:ASN372
|
4.5
|
57.8
|
1.0
|
CD2
|
A:LEU393
|
4.5
|
56.8
|
1.0
|
CB
|
A:ASP369
|
4.6
|
55.6
|
1.0
|
CB
|
A:ASP367
|
4.6
|
54.2
|
1.0
|
CA
|
A:ASN372
|
4.6
|
56.8
|
1.0
|
CA
|
A:ASP367
|
4.7
|
55.0
|
1.0
|
O
|
A:ASN372
|
4.7
|
60.5
|
1.0
|
N
|
A:ASP373
|
4.8
|
57.0
|
1.0
|
N
|
A:GLY394
|
4.8
|
57.8
|
1.0
|
C
|
A:ASP367
|
4.8
|
55.0
|
1.0
|
CA
|
A:ASP369
|
4.9
|
55.0
|
1.0
|
N
|
A:GLY370
|
4.9
|
54.4
|
1.0
|
CB
|
A:LEU393
|
4.9
|
57.2
|
1.0
|
O
|
A:GLY394
|
5.0
|
54.6
|
1.0
|
|
Calcium binding site 4 out
of 6 in 2vdp
Go back to
Calcium Binding Sites List in 2vdp
Calcium binding site 4 out
of 6 in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 4 of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Ca2007
b:63.6
occ:1.00
|
OD1
|
A:ASN430
|
2.2
|
50.0
|
1.0
|
O
|
A:HOH4218
|
2.2
|
47.5
|
1.0
|
O
|
A:TYR432
|
2.3
|
52.6
|
1.0
|
OD2
|
A:ASP434
|
2.4
|
56.2
|
1.0
|
OD1
|
A:ASP426
|
2.4
|
62.9
|
1.0
|
OD1
|
A:ASP428
|
2.5
|
53.2
|
1.0
|
OD1
|
A:ASP434
|
2.6
|
59.9
|
1.0
|
CG
|
A:ASP434
|
2.8
|
57.1
|
1.0
|
CG
|
A:ASN430
|
3.2
|
49.4
|
1.0
|
C
|
A:TYR432
|
3.4
|
53.4
|
1.0
|
CG
|
A:ASP426
|
3.6
|
61.4
|
1.0
|
CG
|
A:ASP428
|
3.6
|
55.2
|
1.0
|
ND2
|
A:ASN430
|
3.9
|
48.8
|
1.0
|
OD2
|
A:ASP428
|
4.0
|
55.3
|
1.0
|
O
|
A:ALA450
|
4.0
|
63.3
|
1.0
|
N
|
A:TYR432
|
4.1
|
53.7
|
1.0
|
CA
|
A:TYR432
|
4.1
|
53.5
|
1.0
|
CB
|
A:TYR432
|
4.2
|
52.7
|
1.0
|
CA
|
A:ASP426
|
4.2
|
60.9
|
1.0
|
CB
|
A:ASN430
|
4.2
|
49.2
|
1.0
|
CB
|
A:ASP434
|
4.3
|
55.4
|
1.0
|
CB
|
A:ASP426
|
4.3
|
61.3
|
1.0
|
N
|
A:ALA450
|
4.4
|
59.5
|
1.0
|
N
|
A:ASN430
|
4.4
|
54.3
|
1.0
|
N
|
A:PRO433
|
4.4
|
53.5
|
1.0
|
OD2
|
A:ASP426
|
4.4
|
60.2
|
1.0
|
N
|
A:ILE427
|
4.4
|
59.3
|
1.0
|
N
|
A:ASP434
|
4.5
|
56.0
|
1.0
|
C
|
A:PRO433
|
4.5
|
56.5
|
1.0
|
N
|
A:ASP428
|
4.5
|
58.4
|
1.0
|
CA
|
A:PRO433
|
4.6
|
54.8
|
1.0
|
C
|
A:ASP426
|
4.7
|
60.6
|
1.0
|
CA
|
A:ASN430
|
4.8
|
50.9
|
1.0
|
CB
|
A:ALA450
|
4.8
|
61.8
|
1.0
|
CA
|
A:ASP434
|
4.8
|
55.1
|
1.0
|
CG
|
A:ARG449
|
4.8
|
59.0
|
1.0
|
CB
|
A:ASP428
|
4.9
|
55.5
|
1.0
|
O
|
A:PRO433
|
4.9
|
58.2
|
1.0
|
N
|
A:ASP429
|
4.9
|
58.7
|
1.0
|
C
|
A:ALA450
|
4.9
|
63.7
|
1.0
|
CA
|
A:ALA450
|
5.0
|
61.5
|
1.0
|
N
|
A:GLY431
|
5.0
|
53.3
|
1.0
|
|
Calcium binding site 5 out
of 6 in 2vdp
Go back to
Calcium Binding Sites List in 2vdp
Calcium binding site 5 out
of 6 in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 5 of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca2002
b:49.7
occ:1.00
|
OD1
|
B:ASP127
|
2.2
|
52.3
|
1.0
|
O
|
B:SER123
|
2.3
|
55.6
|
1.0
|
OD2
|
B:ASP251
|
2.3
|
53.7
|
1.0
|
O
|
C:HOH4006
|
2.3
|
43.5
|
1.0
|
O2
|
B:GOL1462
|
2.3
|
72.8
|
1.0
|
OD1
|
B:ASP126
|
2.5
|
64.5
|
1.0
|
O1
|
B:GOL1462
|
2.8
|
68.3
|
1.0
|
C2
|
B:GOL1462
|
3.2
|
71.4
|
1.0
|
CG
|
B:ASP126
|
3.3
|
65.9
|
1.0
|
CG
|
B:ASP127
|
3.3
|
52.7
|
1.0
|
OD2
|
B:ASP126
|
3.4
|
67.9
|
1.0
|
C
|
B:SER123
|
3.4
|
52.8
|
1.0
|
CG
|
B:ASP251
|
3.5
|
55.2
|
1.0
|
C1
|
B:GOL1462
|
3.5
|
69.5
|
1.0
|
O
|
B:HOH4014
|
3.8
|
56.2
|
1.0
|
OD2
|
B:ASP127
|
3.9
|
52.0
|
1.0
|
CB
|
B:ASP251
|
4.0
|
54.2
|
1.0
|
N
|
B:MET124
|
4.3
|
51.7
|
1.0
|
CA
|
B:SER123
|
4.3
|
54.4
|
1.0
|
CA
|
B:MET124
|
4.4
|
51.0
|
1.0
|
CB
|
B:SER123
|
4.5
|
53.2
|
1.0
|
OD1
|
B:ASP251
|
4.5
|
55.2
|
1.0
|
CB
|
B:ASP127
|
4.5
|
52.7
|
1.0
|
C3
|
B:GOL1462
|
4.6
|
73.0
|
1.0
|
N
|
B:ASP127
|
4.7
|
54.2
|
1.0
|
OXT
|
C:VAL411
|
4.7
|
65.9
|
1.0
|
CB
|
B:ASP126
|
4.8
|
62.8
|
1.0
|
C
|
B:MET124
|
5.0
|
50.5
|
1.0
|
|
Calcium binding site 6 out
of 6 in 2vdp
Go back to
Calcium Binding Sites List in 2vdp
Calcium binding site 6 out
of 6 in the Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv
Mono view
Stereo pair view
|
A full contact list of Calcium with other atoms in the Ca binding
site number 6 of Integrin ALPHAIIBBETA3 Headpiece Bound to Fibrinogen Gamma Chain Peptide,Lggakqagdv within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Ca2003
b:39.9
occ:1.00
|
OD1
|
B:ASN215
|
2.2
|
47.6
|
1.0
|
OD1
|
B:ASP217
|
2.3
|
47.6
|
1.0
|
O
|
B:PRO219
|
2.3
|
53.9
|
1.0
|
O
|
B:ASP217
|
2.3
|
47.5
|
1.0
|
OE2
|
B:GLU220
|
2.4
|
53.5
|
1.0
|
OD2
|
B:ASP158
|
2.4
|
43.0
|
1.0
|
CG
|
B:ASN215
|
3.3
|
48.5
|
1.0
|
CG
|
B:ASP217
|
3.3
|
49.6
|
1.0
|
C
|
B:ASP217
|
3.4
|
50.1
|
1.0
|
C
|
B:PRO219
|
3.4
|
49.0
|
1.0
|
CG
|
B:ASP158
|
3.4
|
44.5
|
1.0
|
CD
|
B:GLU220
|
3.5
|
55.4
|
1.0
|
ND2
|
B:ASN215
|
3.6
|
47.7
|
1.0
|
CB
|
B:ASP158
|
3.8
|
45.4
|
1.0
|
CA
|
B:GLU220
|
3.9
|
48.3
|
1.0
|
N
|
B:ASP217
|
4.0
|
48.3
|
1.0
|
CA
|
B:ASP217
|
4.0
|
50.4
|
1.0
|
OD2
|
B:ASP217
|
4.0
|
48.5
|
1.0
|
N
|
B:GLU220
|
4.1
|
47.9
|
1.0
|
NE2
|
B:HIS255
|
4.1
|
49.7
|
1.0
|
OE1
|
B:GLU220
|
4.1
|
56.6
|
1.0
|
CB
|
B:ASP217
|
4.2
|
50.5
|
1.0
|
C
|
B:ALA218
|
4.3
|
47.2
|
1.0
|
N
|
B:PRO219
|
4.3
|
48.1
|
1.0
|
O
|
B:ALA218
|
4.4
|
45.0
|
1.0
|
CG
|
B:GLU220
|
4.5
|
52.8
|
1.0
|
N
|
B:ALA218
|
4.5
|
50.1
|
1.0
|
CD2
|
B:HIS255
|
4.5
|
50.8
|
1.0
|
CA
|
B:PRO219
|
4.5
|
48.7
|
1.0
|
OD1
|
B:ASP158
|
4.5
|
43.0
|
1.0
|
CB
|
B:GLU220
|
4.6
|
50.8
|
1.0
|
CB
|
B:ASN215
|
4.6
|
48.8
|
1.0
|
CD
|
B:PRO219
|
4.8
|
49.1
|
1.0
|
CA
|
B:ALA218
|
4.9
|
48.7
|
1.0
|
C
|
B:GLU220
|
4.9
|
49.4
|
1.0
|
CB
|
B:TYR164
|
5.0
|
45.6
|
1.0
|
|
Reference:
T.A.Springer,
J.Zhu,
T.Xiao.
Structural Basis For Distinctive Recognition of Fibrinogen Gammac Peptide By the Platelet Integrin ALPHAIIBBETA3. J.Cell Biol. V. 182 791 2008.
ISSN: ISSN 0021-9525
PubMed: 18710925
DOI: 10.1083/JCB.200801146
Page generated: Fri Jul 12 17:57:12 2024
|